10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q3 2022

Filing Information

Form Type	10-Q
Accession Number	`0001213900-22-071154`
Period End Date	20220930
Filing Date	20221110
Fiscal Year	2022
Fiscal Period	Q3
XBRL Instance	f10q0922_relmadatherap_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 52 Income Statement 60 Cash Flow Statement 57 Stockholders Equity 48

Balance Sheet 52 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`Cash`	$42.52M	USD	Point-in-time
Cash and cash equivalents	`Cash`	$44.44M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$167.47M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$141.63M	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	$86.38K	USD	Point-in-time
Lease payments receivable short term	`LeasePaymentsReceivableShortTerm`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$11.30M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$2.95M	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in Dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$223.30M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$187.11M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$16.09K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$28.29K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Total assets	`Assets`	$187.12M	USD	Point-in-time
Total assets	`Assets`	$223.33M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Commitments and Contingencies (See Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (See Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in Dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$11.19M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$10.43M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.74M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	28.64M	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.35M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$3.87M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.74M	shares	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$20.78M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.06M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	28.64M	shares	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value, 200,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Class A convertible preferred stock, $0.001 par value, 3,500,000 shares authorized, none issued and outstanding	`PreferredStockValue1`	-	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 28,641,991 and 27,740,147 shares issued and outstanding, respectively	`CommonStockValue`	$27.74K	USD	Point-in-time
Common stock, $0.001 par value, 150,000,000 shares authorized, 28,641,991 and 27,740,147 shares issued and outstanding, respectively	`CommonStockValue`	$28.64K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$513.30M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$590.48M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-424.17M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-305.07M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$208.26M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$166.34M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$187.12M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$223.33M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-5.36	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-2.44	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-4.04	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareDiluted`	$-1.31	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	17.48M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	29.47M	shares	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$86.45M	USD	3 Qtrs
Weighted average number of common shares outstanding basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	17.04M	shares	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$65.35M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$33.99M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$30.53M	USD	1 Quarter
Weighted average number of common shares outstanding basic and diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.06M	shares	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$26.17M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.66M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$36.09M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$8.21M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$38.74M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$42.65M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$91.52M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$122.55M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-91.52M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-42.65M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-122.55M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-38.74M	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	1 Quarter
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	$6.35M	USD	3 Qtrs
Gain on settlement of fees	`GainLossRelatedToLitigationSettlement`	-	USD	3 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$827.61K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$297.65K	USD	1 Quarter
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.04M	USD	3 Qtrs
Interest/investment income, net	`InterestIncomeExpenseNet`	$1.54M	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-552.17K	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-561.65K	USD	1 Quarter
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-513.33K	USD	3 Qtrs
Realized loss on short-term investments	`RealizedInvestmentGainsLosses`	$-336.95K	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-3.90M	USD	3 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$86.75K	USD	1 Quarter
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-379.70K	USD	3 Qtrs
Unrealized (loss) gain on short-term investments	`UnrealizedGainLossOnInvestments`	$-947.51K	USD	1 Quarter
Total other (expense) income net	`NonoperatingIncomeExpense`	$47.44K	USD	1 Quarter
Total other (expense) income net	`NonoperatingIncomeExpense`	$-681.55K	USD	1 Quarter
Total other (expense) income net	`NonoperatingIncomeExpense`	$147.40K	USD	3 Qtrs
Total other (expense) income net	`NonoperatingIncomeExpense`	$3.45M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-39.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-119.10M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-42.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.37M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.55M	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-1.31	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-5.36	USD	3 Qtrs
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-2.44	USD	1 Quarter
Loss per common share basic and diluted (in Dollars per share)	`EarningsPerShareBasic`	$-4.04	USD	3 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	30.06M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	17.48M	shares	1 Quarter
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	29.47M	shares	3 Qtrs
Weighted average number of common shares outstanding basic and diluted (in Shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	17.04M	shares	3 Qtrs

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-39.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-119.10M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-42.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.37M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.55M	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.26K	USD	3 Qtrs
Depreciation expense	`Depreciation`	-	USD	3 Qtrs
Warrants issued for license agreement	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$10.24M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$22.13M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$32.57M	USD	3 Qtrs
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-552.17K	USD	3 Qtrs
Realized loss on short-term investments	`IncomeLossFromEquityMethodInvestments`	$-513.33K	USD	3 Qtrs
Unrealized loss on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-379.70K	USD	3 Qtrs
Unrealized loss on short-term investments	`UnrealizedlossGainOnShorttermInvestments`	$-3.90M	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-58.97K	USD	3 Qtrs
Lease payment receivable	`IncreaseDecreaseInLeasingReceivables`	$-86.38K	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$1.81M	USD	3 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidExpense`	$-8.36M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$4.36M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-766.66K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$1.28M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$6.48M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-54.21M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-67.92M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$82.48M	USD	3 Qtrs
Purchase of short-term investments	`PaymentsToAcquireInvestments`	$38.99M	USD	3 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$119.54M	USD	3 Qtrs
Sale of short-term investments	`ProceedsFromSaleOfShortTermInvestments`	$60.38M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$21.39M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$37.06M	USD	3 Qtrs
Payment of fees for warrants issued for common stock	`RepaymentsOfNotesPayable`	-	USD	3 Qtrs
Payment of fees for warrants issued for common stock	`RepaymentsOfNotesPayable`	$50.00K	USD	3 Qtrs
Proceeds from issuance of common stock net	`ProceedsFromIssuanceOfCommonStock`	$42.73M	USD	3 Qtrs
Proceeds from issuance of common stock net	`ProceedsFromIssuanceOfCommonStock`	$23.42M	USD	3 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromOptionsExercisedForCommonStock`	$569.43K	USD	3 Qtrs
Proceeds from options exercised for common stock	`ProceedsFromOptionsExercisedForCommonStock`	$703.72K	USD	3 Qtrs
Proceeds from warrants exercised for common stock	`CashlessEexerciseOfWarrants`	$-1.23M	USD	3 Qtrs
Proceeds from warrants exercised for common stock	`CashlessEexerciseOfWarrants`	$-2.12M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$26.10M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$44.61M	USD	3 Qtrs
Net (decrease) / increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$8.95M	USD	3 Qtrs
Net (decrease) / increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-1.92M	USD	3 Qtrs
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.45M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$42.52M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$11.45M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$42.52M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$2.50M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$44.44M	USD	Point-in-time
Interest	`InterestPaidNet`	-	USD	3 Qtrs
Interest	`InterestPaidNet`	-	USD	3 Qtrs
Share exchange for Pre-funded warrants	`CashlessExerciseOfOptionsForCommonStock`	-	USD	3 Qtrs
Share exchange for Pre-funded warrants	`CashlessExerciseOfOptionsForCommonStock`	$1.45K	USD	3 Qtrs

Stockholders Equity 48 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$166.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$96.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$196.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance	`StockholdersEquity`	$72.69M	USD	Point-in-time
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$8.34M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$8.01M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$8.27M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$5.85M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$12.30M	USD	1 Quarter
Stock based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions`	$11.93M	USD	1 Quarter
ATM offering, net of offering costs	`ProceedsFromIssuanceInitialPublicOffering`	$23.46M	USD	1 Quarter
ATM offering, net of offering costs	`ProceedsFromIssuanceInitialPublicOffering`	$13.15M	USD	1 Quarter
ATM offering, net of offering costs	`ProceedsFromIssuanceInitialPublicOffering`	$29.58M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$481.45K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$1.46M	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$332.92K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$300.01K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$175.01K	USD	1 Quarter
Warrant exercised for cash	`WarrantExercisedForCash`	$595.35K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$352.74K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$64.80K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$52.16K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$467.77K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$286.18K	USD	1 Quarter
Options exercised for cash	`OptionExercisedForCash`	$49.50K	USD	1 Quarter
Equity offering costs	`StockIssuedDuringPeriodValueOther`	$-42.01K	USD	1 Quarter
Share exchange Pre-funded warrants, net of fees	`VenrockShareExchangePrefundedWarrantsNetOfFees`	$50.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-39.42M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-119.10M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-39.75M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-42.61M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.37M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-39.93M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-22.22M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-26.55M	USD	1 Quarter
Balance	`StockholdersEquity`	$208.26M	USD	Point-in-time
Balance	`StockholdersEquity`	$105.58M	USD	Point-in-time
Balance	`StockholdersEquity`	$166.34M	USD	Point-in-time
Balance	`StockholdersEquity`	$96.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$196.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$91.15M	USD	Point-in-time
Balance	`StockholdersEquity`	$210.40M	USD	Point-in-time
Balance	`StockholdersEquity`	$72.69M	USD	Point-in-time
Warrants issued for license agreement	`StockIssuedDuringPeriodWarrantsIssuedForLicenseAgreement`	$10.24M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.